Clinical Trials Browser

Has results × Squamous Cell Carcinoma of Head and Neck × cabozantinib × Clear all

NCT03468218 2026-01-23

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Phase 2 Active not recruiting

36 enrolled 11 charts

Squamous Cell Carcinoma of Head and Neck